Abstract:A single atom Gd‐based magnetic resonance imaging (MRI) CA (feGd‐NxC) with concurrently improved relaxivity and stability is fabricated through spatial confined thermal calcination and controllable chemical etching methods. The afforded feGd‐NxC can potentially be utilized as contrast agents both for T1 and T2 weighted MRI, offering self‐confirmative properties for in vivo diagnosis. Gadolinium (Gd)‐based complexes are extensively utilized as contrast agents (CAs) in magnetic resonance imaging (MRI), yet, suffer from potential safety concerns and poor tumor targeting. Herein, as a mimic of Gd complex, single‐atom Gd nanoprobes with r1 and r2 values of 34.2 and 80.1 mM−1 s−1 (far higher than that of commercial Gd CAs) at 3 T are constructed, which possessed T1/T2 dual‐mode MRI with excellent stability and good tumor targeting ability. Specifically, single‐atom Gd is anchored on nitrogen‐doped carbon matrix (Gd‐NxC) through spatial‐confinement method, which is further subjected to controllable chemical etching to afford fully etched bowl‐shape Gd‐NxC (feGd‐NxC) with hydrophilic properties and defined coordination structure, similar to commercial Gd complex. Such nanostructures not only maximized the Gd3+ site exposure, but also are suitable for self‐confirmative diagnosis through one probe with dual‐mode MRI. Moreover, the strong electron localization and interaction between Gd and N atoms afforded feGd‐NxC excellent kinetic inertness and thermal stability (no significant Gd3+ leaching is observed even incubated with Cu2+ and Zn2+ for two months), providing a creative design protocol for MRI CAs.

Enhancing the magnetic relaxivity of MRI contrast agents via the localized superacid microenvironment of graphene quantum dots

Synergistic Effect of Oxygen- and Nitrogen-Containing Groups in Graphene Quantum Dots: Red Emitted Dual-Mode Magnetic Resonance Imaging Contrast Agents with High Relaxivity

Easy preparation of an MRI contrast agent with high longitudinal relaxivity based on gadolinium ions-loaded graphene oxide

Geometrical Confinement of Gadolinium Oxide Nanoparticles in Poly(ethylene Glycol)/arginylglycylaspartic Acid-Modified Mesoporous Carbon Nanospheres As an Enhanced T1 Magnetic Resonance Imaging Contrast Agent.

PEGylation of Protein-Based MRI Contrast Agents Improves Relaxivities and Biocompatibilities.

High relaxivity Gd3+-based organic nanoparticles for efficient magnetic resonance angiography

Formation of Nanosized Gd(III) Coordination Networks with Tripodal Amine-N-oxide Type Ligand Through Microemulsions to Achieve High Relaxivity and Exceptional Stability for MRI Applications

Exceedingly Small Gadolinium Oxide Nanoparticles with Remarkable Relaxivities for Magnetic Resonance Imaging of Tumors

Adaption of the structure of carbon nanohybrids toward high-relaxivity for a new MRI contrast agent

Gd-Dots with Strong Ligand-Water Interaction for Ultrasensitive Magnetic Resonance Renography

Single‐Atom Gd Nanoprobes for Self‐Confirmative MRI with Robust Stability

Facile Preparation of a New Gadofullerene-Based Magnetic Resonance Imaging Contrast Agent with High 1H Relaxivity

Single-Atom Gadolinium Anchored on Graphene Quantum Dots As a Magnetic Resonance Signal Amplifier

Reductive Microenvironment Responsive Gadolinium-Based Polymers As Potential Safe MRI Contrast Agents

Facile preparation of gadolinium(III) chelates functionalized carbon quantum dot-based contrast agent for magnetic resonance/fluorescence multimodal imaging

Gadolinium(III) Chelated Conjugated Polymer As a Potential MRI Contrast Agent

Ultrasmall gadolinium hydrated carbonate nanoparticle: An advanced T 1 MRI contrast agent with large longitudinal relaxivity

Oxygen Vacancy Enables Markedly Enhanced Magnetic Resonance Imaging-Guided Photothermal Therapy of a Gd3+-Doped Contrast Agent

Maximizing the Relaxivity of Gd-Complex by Synergistic Effect of Hsa and Carboxylfullerene

Application of Gd(III) Complexes for Magnetic Resonance Imaging and the Improvement of Relaxivities Via Nanocrystallization

Gadolinium(III)-based Polymeric Magnetic Resonance Imaging Agents for Tumor Imaging